Statement of Changes in Net Assets/Equity Business Type Income as of June 30, 2021
Statement of Changes in Net Assets/Equity Internally Generated Income as of June 30, 2021
Statement of Changes in Net Assets/Equity Regular Agency Fund as of June 30, 2021
Statement of Changes in Net Assets/Equity Trust Receipt as of June 30, 2021
Trial Balance Trust Receipt as of July 31, 2021
Trial Balance Regular Agency Fund as of July 31, 2021
Trial Balance Regular Agency Fund as of June 30, 2021
Trial Balance Trust Receipt as of June 30, 2021
Trial Balance Internally Generated Income as July 31, 2021
Trial Balance Internally Generated Income as of June 30, 2021
Trial Balance Business Type Income as of July 31, 2021
Trial Balance Business Type Income as of June 30, 2021
Detailed Statement of Financial Position Trust Receipt as of June 30, 2021
Detailed Statement of Financial Position Regular Agency Fund as of June 30, 2021
Detailed Statement of Financial Position Internally Generated Income as of June 30, 2021
Detailed Statement of Financial Position Business Type Income as of June 30, 2021
Detailed Statement of Financial Performance Regular Agency Fund for the Period ending June 30, 2021
Detailed Statement of Financial Performance Business Type Income for the Period ending June 30, 2021
Detailed Statement of Cash Flows Trust Receipt for the Period January 1, 2021 to June 30, 2021
Detailed Statement of Cash Flows Regular Agency Fund for the Period January 1, 2021 to June 30, 2021
Condensed Statement of Financial Position Business Type Income as of June 30, 2021
Condensed Statement of Financial Position Trust Receipt as of June 30, 2021
Condensed Statement of Financial Position Regular Agency Fund as of June 30, 2021
Condensed Statement of Financial Position Internally Generated Income as of June 30, 2021
Condensed Statement of Financial Performance Trust Receipt for the Period ending June 30, 2021
Condensed Statement of Financial Performance Regular Agency Fund for the Period ending June 30, 2021
Condensed Statement of Cash Flows Trust Receipt for the Period January 1, 2021 to June 30, 2021
Trial Balance Trust Receipt as of May 31, 2021
Trial Balance Business Type Income as of May 31, 2021
Trial Balance Regular Agency Fund as of May 31, 2021
Trial Balance Internally Generated Income as of May 31, 2021
Trial Balance Trust Receipt as of April 30, 2021
Trial Balance Business Type Income as of April 30, 2021
Trial Balance Regular Agency Fund as of April 30, 2021
Trial Balance Internally Generated Income as of April 30, 2021
Condensed Statement of Cash Flows Trust Receipt for the Period January 01, 2021 to March 31, 2021
Condensed Statement of Financial Performance Trust Receipt for the Period ending March 31, 2021
Condensed Statement of Financial Position Business Type Income as of March 31, 2021
Condensed Statement of Financial Position Internally Generated Income as of March 31, 2021
Condensed Statement of Financial Position Regular Agency Fund as of March 31, 2021
Condensed Statement of Financial Position Trust Receipt as of March 31, 2021
Detailed Statement of Cash Flows Trust Receipt for the Period January 01, 2021 to March 31, 2021
Detailed Statement of Financial Performance Regular Agency Fund for the Period ending March 31, 2021
Detailed Statement of Financial Performance Trust Receipt for the period ending March 31, 2021
Detailed Statement of Financial Position Business Type Income as of March 31, 2021
Detailed Statement of Financial Position Internally Generated Income as of March 31, 2021
Detailed Statement of Financial Position Regular Agency Fund as of March 31, 2021
Detailed Statement of Financial Position Trust Receipt as of March 31, 2021
Statement of Changes in Net Assets/Equity Regular Agency Fund as of March 31, 2021
Statement of Changes in Net Assets/Equity Business Type Income as of March 31, 2021
Statement of Changes in Net Assets/Equity Trust Receipt as of March 31, 2021
Statement of Changes in Net Assets/Equity Internally Generated Income as of March 31, 2021
FY 2021 Monthly Disbursement Program